What is the registration number for MERGING CLASSICAL PHARMACEUTICS WITH CUTTING EDGE INNOVATION AND TECHNOLOGY?

MERGING CLASSICAL PHARMACEUTICS WITH CUTTING EDGE INNOVATION AND TECHNOLOGY is registered under USPTO registration number 5846995.

MER

USPTO Trademark Record

ABANDONED

MERGING CLASSICAL PHARMACEUTICS WITH CUTTING EDGE INNOVATION AND TECHNOLOGY

Q: Who owns the MERGING CLASSICAL PHARMACEUTICS WITH CUTTING EDGE INNOVATION AND TECHNOLOGY trademark?

The MERGING CLASSICAL PHARMACEUTICS WITH CUTTING EDGE INNOVATION AND TECHNOLOGY trademark is owned by Bravado Pharmaceuticals, LLC.

Q: What class is the MERGING CLASSICAL PHARMACEUTICS WITH CUTTING EDGE INNOVATION AND TECHNOLOGY trademark registered in?

The MERGING CLASSICAL PHARMACEUTICS WITH CUTTING EDGE INNOVATION AND TECHNOLOGY trademark is registered in Class 042 (Scientific, technology & SaaS services).

Q: What is the serial number for MERGING CLASSICAL PHARMACEUTICS WITH CUTTING EDGE INNOVATION AND TECHNOLOGY?

The USPTO serial number for MERGING CLASSICAL PHARMACEUTICS WITH CUTTING EDGE INNOVATION AND TECHNOLOGY is 88155761.

SN 88155761·Reg 5846995·Filed Oct 15, 2018

Owner Bravado Pharmaceuticals, LLC

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

MERGING CLASSICAL PHARMACEUTICS WITH CUTTING EDGE INNOVATION AND TECHNOLOGY (Serial No. 88155761), Registration No. 5846995, is a abandoned US trademark filed on Oct 15, 2018 by Bravado Pharmaceuticals, LLC. This trademark covers Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

MERGING CLASSICAL PHARMACEUTICS WITH CUTTING EDGE INNOVATION AND TECHNOLOGY (Reg. #5846995) is an abandoned US trademark that was filed in 2018 but has since been abandoned. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Oct 15, 2018

SERIAL

88155761

REG#

5846995

REGISTERED

Aug 27, 2019

Owner

Applicant

Bravado Pharmaceuticals, LLC

Entity

LLC

State

Address

27105 Brush Creek Way, Wesley Chapel, FL, 33544

Country

Attorney

NameLinda Graham

Law firm

LINDA GRAHAM DUNLAP BENNETT & LUDWIG

Docket

49538

Address

211 CHURCH STREET SE, LEESBURG, VA 20175, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateOct 15, 2018

Serial Number88155761

Registration No.5846995

Registration DateAug 27, 2019

Status DateMar 13, 2026

Published for OppositionMar 12, 2019

Mark TypeStandard characters

Attorney Docket49538

Status DescriptionDead and cancelled, Section 8

Filing Signals

FILED

2018

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Apr 15, 2018

First use in commerce: Apr 15, 2018

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

17 events

CANCELLED SEC. 8 (6-YR)

Mar 13, 2026

CANCELLED SEC. 8 (6-YR)

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Aug 27, 2024

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-PRINCIPAL REGISTER

Aug 27, 2019

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jul 20, 2019

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jul 19, 2019

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

STATEMENT OF USE PROCESSING COMPLETE

Jul 03, 2019

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jul 02, 2019

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

Jun 15, 2019

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Jun 15, 2019

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

May 07, 2019

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Mar 12, 2019

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 12, 2019

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 20, 2019

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 25, 2019

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Jan 24, 2019

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 25, 2018

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Oct 18, 2018

NEW APPLICATION ENTERED

MERGING CLASSICAL PHARMACEUTICS WITH CUTTING EDGE INNOVATION AND TECHNOLOGY

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Bravado Pharmaceuticals, LLC

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Linda Graham

Resources

Company